Australian panel recommends transparency overhaul at TGA
This article was originally published in SRA
Executive Summary
Australia's Therapeutic Goods Administration's "should move away from the conservative approach that has characterised its actions in the past and recognise that it has a duty to collaborate with stakeholders to create a culture in which the community has confidence in the therapeutic goods the TGA regulates". This is the conclusion of the government-constituted panel that was tasked with assessing, and suggesting recommendations for improving, the transparency of the TGA's regulatory decision-making processes.